Apogee Biotechnology Corporation was founded in 2001 by Charles D. Smith, Ph.D. and is based at the Hershey Center for Applied Research in Hershey, Pennsylvania.
The Company is privately held and has been financed through mainly grants, including small business innovative research (SBIR) grants from the NIH and biotechnology grants from the Pennsylvania Department of Health.
We are currently dedicated to developing our sphingosine kinase inhibitor, opagnib, for the treatment of obesity.